Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/18/2008 | US7453027 Lettuce cultivar 21-0406192-B |
11/18/2008 | US7453026 Lettuce cultivar 51-0501050-B |
11/18/2008 | US7453025 genetic ablation of reproductive tissues in angiosperm and gymnosperm species; transgenic plant, H102E barnase mutant is capable of disrupting reproductive development of at least one of a male reproductive structure in a plant |
11/18/2008 | US7453024 for production of natural flavors, fragrances or bio-control agents capable of synthesizing a monoterpene alcohol linalool when contacted with geranyl diphosphate (GPP) and/or a sesquiterpene alcohol nerolidol with farnesyl diphosphate (FPP) |
11/18/2008 | US7453023 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
11/18/2008 | US7453022 Method of increasing the content of selected transgene-coded proteins or peptides in plants |
11/18/2008 | US7453021 Genetic engineering of metalloproteinase; phenotype indicator of bone disorders |
11/18/2008 | US7452988 Expression vector comprising antisense nucleotide sequence associated with suppression of polynucleotides coding enzymatic polypeptide associated with the conversion of 1-propenylsulfenic acid to thiopropanal S-oxide; transgenic plants and food processing |
11/18/2008 | US7452987 Interfering RNA molecules |
11/18/2008 | US7452986 Plastid promoters for transgene expression in the plastids of higher plants |
11/18/2008 | US7452985 Human Ron-related gene variant associated with cancers |
11/18/2008 | US7452983 Protein which binds to Akt2 |
11/18/2008 | US7452981 derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells; rheumatoid arthritis, type I diabetes, multiple sclerosis, Crohn's disease, ulcerative colitis, atopic dermatitis, etc. |
11/18/2008 | US7452980 Compositions and methods for the diagnosis and treatment of immune disorders |
11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
11/18/2008 | US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy |
11/18/2008 | US7452973 modified by substituting negatively charged amino acids with positively charged amino acids on the exterior of the protein making the protein cell permeable; obviates the need for transfections |
11/18/2008 | US7452972 Nucleic acids and proteins showing increased expression dose under salt stress |
11/18/2008 | US7452970 G-protein coupled receptors for identifying modulators for prevention and treatment of cardiovascular, urogenital and hypertensive disorders |
11/18/2008 | US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues |
11/18/2008 | US7452869 For modulating necrosis and treating neurological/ cardiovascular diseases |
11/18/2008 | US7452859 Having serine protease inhibitory activity |
11/18/2008 | US7452722 Methods for developing conifer somatic embryos |
11/18/2008 | US7452717 Carboxylesterase; antitumor agents; drug screening; bioassay |
11/18/2008 | US7452716 Plasmid for use as gene transfer vechicle in the treatment of genetic disorders |
11/18/2008 | US7452715 expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter; bacterial host cell transformed, transduced or transfected with the plasmid |
11/18/2008 | US7452710 Process for the biological production of 1,3-propanediol with high titer |
11/18/2008 | US7452709 Method of screening prion disease infection factor |
11/18/2008 | US7452707 Cellobiohydrolases-1 (CBH-1) for use as hydrolyzing tool in textile treatment, papermaking, detergents and animal feeds |
11/18/2008 | US7452706 Recombinant bacterial phytases and uses thereof |
11/18/2008 | US7452705 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system disorders |
11/18/2008 | US7452704 Dehydrogenase and a gene encoding the same |
11/18/2008 | US7452696 Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo |
11/18/2008 | US7452695 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free |
11/18/2008 | US7452694 Identifying modulators of g-protein coupled receptor associated with taste/flavor transduction; food processing and artificial sweetners |
11/18/2008 | US7452693 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain |
11/18/2008 | US7452685 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
11/18/2008 | US7452682 Identification of 5HT2A receptor ligands by selective amplification of cells transfected with receptors |
11/18/2008 | US7452675 Useful in identifying molecules, that bind TRPM4b (transmembrane channel polypeptides) which modulate TRPM4b ion channel activity, and/or which alter expression of TRPM4b within cells |
11/18/2008 | US7452668 Using matrix composed of immobilized probed comprising 5'-acrylamide moiety to separate and identify preferential single stranded DNA molecules in electric field |
11/18/2008 | US7452666 Comprises pipetting robot or voltage-driven fluidic transport for hybridization |
11/18/2008 | US7452543 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
11/18/2008 | US7452542 Live attenuated coronavirus vaccines |
11/18/2008 | US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences |
11/18/2008 | US7452531 Compositions and methods for tumor-targeted delivery of effector molecules |
11/18/2008 | CA2588106A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof |
11/18/2008 | CA2501743C Gas driven gene delivery instrument |
11/18/2008 | CA2440399C Epitope testing using hla |
11/18/2008 | CA2437201C Methods and compositions useful for stimulating an immune response |
11/18/2008 | CA2424624C Expression vectors with modified cole1 origin of replication for control of plasmid copy number |
11/18/2008 | CA2394984C Novel plant expression constructs |
11/18/2008 | CA2381219C Monomeric protein of the tgf-beta family |
11/18/2008 | CA2366732C Homogenising of small-volume mixtures by centrifugation and heating |
11/18/2008 | CA2360322C New hydrophobic polymer comprising fluorine moieties |
11/18/2008 | CA2330837C A vector expressing an rna viral full-length gene and its use |
11/18/2008 | CA2325468C Rolling circle replication of padlock probes |
11/18/2008 | CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/18/2008 | CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
11/18/2008 | CA2252968C Modified dna-polymerase from carboxydothermus hydrogeno-formans and its use for coupled reverse transcription and polymerase chain reaction |
11/18/2008 | CA2238948C Starch branching enzyme ii of potato |
11/18/2008 | CA2232673C Container for drying biological samples, method of making such container, and method of using same |
11/18/2008 | CA2224470C Modification of plant lipids and seed oils utilizing yeast slc genes |
11/18/2008 | CA2223047C Micelle protection assay |
11/18/2008 | CA2210491C Antagonists of interleukin-15 |
11/18/2008 | CA2193993C New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4 |
11/18/2008 | CA2184635C Combined use of genetic markers for the diagnosis of alzheimer's disease, diagnostic kit and method |
11/18/2008 | CA2172376C Antibodies to cd40 |
11/18/2008 | CA2157975C Recombinant mersacidin and a method for production |
11/18/2008 | CA2136230C Clostridium perfringens vaccines |
11/18/2008 | CA2116239C Gene probe biosensor method |
11/18/2008 | CA2095421C Novel amyloid precursor proteins and methods of using same |
11/18/2008 | CA1341585C Recombinant retroviruses |
11/18/2008 | CA1341584C Method of amplifying and detecting nucleic acid sequences |
11/18/2008 | CA1341583C Interferons and process for their preparation |
11/13/2008 | WO2008137985A2 Methods for inducing cotton embryogenic callus |
11/13/2008 | WO2008137981A1 Human parainfluenza viruses having separated p and c genes |
11/13/2008 | WO2008137881A2 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
11/13/2008 | WO2008137814A1 Methods for assessing the delivery of small inhibitory rna molecules |
11/13/2008 | WO2008137776A2 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
11/13/2008 | WO2008137775A2 RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
11/13/2008 | WO2008137771A2 RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE ( PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
11/13/2008 | WO2008137761A2 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
11/13/2008 | WO2008137758A2 Amino acid lipids and uses thereof |
11/13/2008 | WO2008137751A2 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
11/13/2008 | WO2008137532A1 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
11/13/2008 | WO2008137516A1 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
11/13/2008 | WO2008137470A1 Multi-chain lipophilic polyamines |
11/13/2008 | WO2008137165A1 Anti-glycated cd59 antibodies and uses thereof |
11/13/2008 | WO2008137163A1 Two-component genome flavivirus and uses thereof |
11/13/2008 | WO2008137108A2 Plants having enhanced yield-related traits and a method for making the same |
11/13/2008 | WO2008136902A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
11/13/2008 | WO2008136848A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
11/13/2008 | WO2008136797A1 Method for micropropagation of monocots based on sustained totipotent cell cultures |
11/13/2008 | WO2008136790A1 Dna plasmids having improved expression and stability |
11/13/2008 | WO2008136748A1 Tumour growth inhibitory compounds and methods of their use |
11/13/2008 | WO2008136670A2 Improved methods and means for lentiviral gene delivery |
11/13/2008 | WO2008136656A1 Improved methods and means for lentiviral gene delivery |
11/13/2008 | WO2008136470A1 Hcv gene |
11/13/2008 | WO2008136451A1 Sphingomyelinase |
11/13/2008 | WO2008136438A1 Viral vector for gene therapy |